WordNet

relating to or having the characteristics of a family; "children of the same familial background"; "familial aggregation"
occurring among members of a family usually by heredity; "an inherited disease"; "familial traits"; "genetically transmitted features" (同)genetic, hereditary, inherited, transmitted, transmissible

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9.

Page MM1, Stefanutti C2, Sniderman A3, Watts GF1.
Clinical science (London, England : 1979).Clin Sci (Lond).2015 Jul;129(1):63-79. doi: 10.1042/CS20140755.
Familial hypercholesterolaemia (FH) is an autosomal co-dominant disorder that markedly raises plasma low-density lipoprotein-cholesterol (LDL-C) concentration, causing premature atherosclerotic coronary artery disease (CAD). FH has recently come under intense focus and, although there is general con
PMID 25881720

Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease.

Al-Allaf FA1, Athar M2, Abduljaleel Z3, Taher MM4, Khan W5, Ba-Hammam FA6, Abalkhail H7, Alashwal A7.
Gene.Gene.2015 Jul 1;565(1):76-84. doi: 10.1016/j.gene.2015.03.064. Epub 2015 Apr 1.
Familial hypercholesterolemia (FH) is an autosomal dominant inherited disease characterized by elevated plasma low-density lipoprotein cholesterol (LDL-C). It is an autosomal dominant disease, caused by variants in Ldlr, ApoB or Pcsk9, which results in high levels of LDL-cholesterol (LDL-C) leading
PMID 25839937

Joyce N1, Wellenius GA2, Dore DD3, Newburger JW4, Zachariah JP4.
The Journal of pediatrics.J Pediatr.2015 Jul;167(1):113-119.e1. doi: 10.1016/j.jpeds.2015.04.004. Epub 2015 May 4.
OBJECTIVES: Pediatric guidelines in 2008 and 2011 recommended lipid lowering therapy in children ≥8 years of age with high-risk cardiovascular conditions, such as familial hypercholesterolemia (FH). Our objective was to describe the patterns and predictors of lipid lowering therapy initiation in c
PMID 25953004

Molecular Genetic Diagnosis of a Family with Hypercholesterolemia by a Mismatched PCR-RFLP Method for Genotyping Single Base Substitution of the LDL Receptor Gene.

, , , , ,
Japanese Heart Journal 39(5), 681-686, 1998
… Defects at some of these loci account for specific types of dyslipoproteinemia occurring with regularity among family members. … In the course of familial investigations of coronary artery disease, we identified an family in which several members were affected with elevated low density lipoprotein (LDL) cholesterol levels. …
NAID 130000766957

Type III dyslipoproteinemia in patients heterozygous for familial hypercholesterolemia and apolipoprotein E2 Evidence for a gene-gene interaction

Type III dyslipoproteinemia in patients heterozygous for familial hypercholesterolemia and apolipoprotein E2 : Evidence for a gene-gene interaction.

リンク元	「家族性高リポ蛋白血症III型」「家族性異常βリポタンパク血症」
関連記事	「familial」「dyslipoproteinemia」